Aldurazyme and tachypnoea Patient Reports February 12, 2012

Aldurazyme Side Effects Report #6020709-6
Aldurazyme side effect was reported by a Physician from BRAZIL on Dec 05, 2008. Male patient, child 6 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: diarrhoea, infusion related reaction, pyrexia, sinusitis , tachycardia, tachypnoea. Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5297533-5
Aldurazyme side effect was reported by a Physician from COLOMBIA on Mar 21, 2007. Male patient, child 5 years of age, weighting 33.07 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cyanosis, diarrhoea, dyspnoea, pyrexia, tachypnoea, tremor, vomiting. Aldurazyme dosage: 0.58 MG/KG QWK IV. During the same period patient was treated with LEVOTIROXINE, LORATADINE. Patient recovered.

Aldurazyme Side Effects Report #5762050-2
Aldurazyme side effect was reported by a Physician from COLOMBIA on May 20, 2008. Female patient, child 3 years of age, weighting 26.46 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cyanosis, headache , hydrocephalus , infusion related reaction, oxygen saturation decreased, pneumonia , tachypnoea, vomiting. Aldurazyme dosage: 0.5 MG/KG, INTRAVENOUS. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE, SALBUTAMOL, NIFEDIPINE, RANITIDINE, FUROSEMIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5486000-1
Aldurazyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 28, 2007. Female patient, 27 years of age, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: chest discomfort, heart rate decreased, increased appetite, tachypnoea. Aldurazyme dosage: 0.58 MG/KG QWK IV. Patient recovered.


Aldurazyme Side Effects Report #5500332-X
Aldurazyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 12, 2007. Female patient, 27 years of age, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: chest discomfort, heart rate decreased, tachypnoea. Aldurazyme dosage: 0.58 MG/KG QWK IV. Patient recovered.

Aldurazyme Side Effects Report #5642669-X
Aldurazyme side effect was reported by a Physician from COLOMBIA on Feb 08, 2008. Female patient, child 2 years of age, weighting 25.57 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cyanosis, heart rate increased, oxygen saturation decreased, respiratory rate increased, tachypnoea. Aldurazyme dosage: 0.5 MG/KG, INTRAVENOUS. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE, SALBUTAMOL, NIFEDIPINE. Patient recovered.

Aldurazyme Side Effects Report #5920980-2
Aldurazyme side effect was reported by a Physician from BRAZIL on Oct 01, 2008. Male patient, child 11 years of age, weighting 101.4 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: dyspnoea, infusion related reaction, tachycardia, tachypnoea, urticaria. Aldurazyme dosage: 23.2 MG, 1X/W, INTRAVENOUS. Patient recovered.

Aldurazyme Side Effects Report #5389805-0
Aldurazyme side effect was reported by a Physician from COLOMBIA on Feb 13, 2007. Female patient, weighting 33.07 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cyanosis, irritability, oxygen saturation decreased, pyrexia, tachycardia, tachypnoea, tremor. Aldurazyme dosage: 8.7 MG, IV. During the same period patient was treated with ACETAMINOPHEN, ENALAPRIL MALEATE, AMLODIPINE, CHLORPHENIRAMINE MALEATE. Patient recovered.

Aldurazyme Side Effects Report #5390731-1
Aldurazyme side effect was reported by a Physician from JAPAN on Dec 09, 2005. Female patient, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cough, mood altered, otitis media, otorrhoea, pharyngeal erythema, pharyngitis, respiratory syncytial virus infection , tachypnoea, wheezing. Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.


Aldurazyme Side Effects Report #5616219-8
Aldurazyme side effect was reported by a Health Professional from AUSTRALIA on Jan 20, 2008. Male patient was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: chills, hypotension, livedo reticularis, nonspecific reaction, peripheral circulatory failure, pyrexia, supraventricular tachycardia, tachypnoea, vasoconstriction. Aldurazyme dosage: unknown. Patient recovered.

Aldurazyme Side Effects Report #4848745-3
Aldurazyme side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: otitis media, pharyngitis, respiratory syncytial virus infection , tachypnoea. Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5880674-9
Aldurazyme side effect was reported by a Physician from BRAZIL on Aug 28, 2008. Male patient, child 11 years of age, weighting 101.4 lb, was diagnosed with mucopolysaccharidosis and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: infusion related reaction, tachycardia, tachypnoea, urticaria. Aldurazyme dosage: 23.2 MG, 1X/W, INTRAVENOUS. Patient recovered.